These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 2890779

  • 1. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding.
    Mikashima H, Takehara S, Muramoto Y, Khomaru T, Terasawa M, Tahara T, Maruyama Y.
    Jpn J Pharmacol; 1987 Aug; 44(4):387-91. PubMed ID: 2890779
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
    Takehara S, Mikashima H, Muramoto Y, Terasawa M, Setoguchi M, Tahara T.
    Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
    [Abstract] [Full Text] [Related]

  • 3. Antagonistic activity of etizolam on platelet-activating factor in vivo experiments.
    Terasawa M, Mikashima H, Tahara T, Maruyama Y.
    Jpn J Pharmacol; 1987 Aug; 44(4):381-6. PubMed ID: 3682404
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T, Saito M, Mase T, Hara H, Nagaoka H, Murase K, Tomioka K.
    Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
    [Abstract] [Full Text] [Related]

  • 8. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
    Herbert JM, Laplace MC, Maffrand JP.
    J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.
    Nunez D, Kumar R, Hanahan DJ.
    Arch Biochem Biophys; 1989 Aug 01; 272(2):466-75. PubMed ID: 2502069
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
    Robaut C, Durand G, James C, Lave D, Sedivy P, Floch A, Mondot S, Pacot D, Cavero I, Le Fur G.
    Biochem Pharmacol; 1987 Oct 01; 36(19):3221-9. PubMed ID: 2822048
    [Abstract] [Full Text] [Related]

  • 14. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM, Bernat A, Valette G, Gigo V, Lale A, LaPlace MC, Lespy L, Savi P, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1991 Oct 01; 259(1):44-51. PubMed ID: 1656029
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
    Lee LW, Peng HC, Ko WC, Hung WC, Su CH, Lin CH, Huang TF, Yen MH, Sheu JR.
    Eur J Pharmacol; 1999 Jan 08; 364(2-3):239-46. PubMed ID: 9932729
    [Abstract] [Full Text] [Related]

  • 17. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Alberts AW, Bugianesi RL, Chabala JC, Ponpipom MM.
    J Pharmacol Exp Ther; 1988 Aug 08; 246(2):534-41. PubMed ID: 2841449
    [Abstract] [Full Text] [Related]

  • 18. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L, Floch A, Mondot S, Cavero I.
    Mol Pharmacol; 1988 Aug 08; 34(2):145-51. PubMed ID: 2842653
    [Abstract] [Full Text] [Related]

  • 19. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism.
    Nunez D, Randon J, Gandhi C, Siafaka-Kapadai A, Olson MS, Hanahan DJ.
    J Biol Chem; 1990 Oct 25; 265(30):18330-8. PubMed ID: 2170407
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
    Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MH, Wu MS, Wang X, Han GQ, Li RZ.
    Proc Natl Acad Sci U S A; 1985 Feb 25; 82(3):672-6. PubMed ID: 2983307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.